School of Medicine


Showing 11-19 of 19 Results

  • Christina (Christy) Tise, MD, PhD

    Christina (Christy) Tise, MD, PhD

    Clinical Instructor, Pediatrics - Medical Genetics

    BioDr. Christina (Christy) Tise is a physician scientist and Assistant Professor in the Division of Medical Genetics at Stanford with subspecialty training in Clinical Biochemical Genetics. Dr. Tise has developed multiple research projects focused on the clinical impact of biochemical genetic conditions in pregnancy and newborn health, including a project focused on unforeseen diagnoses in individuals initially identified through state newborn screening which has resulted in a number of publications.

    Dr. Tise also researches the genetic etiologies of recurrent pregnancy loss and the impact of inherited metabolic conditions on human reproduction. She is involved in several research initiatives including contributing to the development of TRIOS, a multi-site, NIH-funded research study to evaluate the genetic causes of recurrent pregnancy loss. In serving as the primary research mentor for a recent Masters of Genetic Counseling graduate, Dr. Tise’s research on carrier and newborn screening has highlighted areas of ancestry-related healthcare inequities specific to the field of Medical Genetics.

    Dr. Tise’s primary academic and advocacy interests are embodied in this work, specifically the overlap between biochemical and molecular analysis, and the clinical utility of innovative technologies for diagnosis and treatment of genetic disease. This is an unbelievably thrilling time for the field of Medical Genetics, as it promises immense progress and opportunity for all fields of medicine, and Dr. Tise is determined, honored, and incredibly excited to be a part of it!

    Research interests: newborn screening, carrier screening, prenatal screening, genetics of recurrent pregnancy loss, biochemical genetics, novel gene discovery, variant interpretation, founder populations, diagnostic genetic testing, bioethics, GWAS/ExWAS

  • Sara L. (Sally) Tobin

    Sara L. (Sally) Tobin

    Sr Research Scholar, Pediatrics - Center for Biomedical Ethics

    Current Research and Scholarly InterestsTobin is a Senior Research Scholar at the Stanford Center for Biomedical Ethics. She obtained her Ph.D. in Developmental Biology from the University of Washington and did postdoctoral research in Genetics at the University of California, Berkeley and in Biochemistry at the University of California, San Francisco. She became a faculty member at the University of Oklahoma College of Medicine in 1983 and moved to Stanford University in 1996. Her research contributions have been published in prestigious journals such as Cell, Nature, Genes & Development, Neuron, and Journal of Cell Biology.

    Projects

    With her collaborator, graphic designer Ann Boughton, Tobin has completed the production of three educational multimedia CD-ROM discs about the genetic revolution in medical care sparked by the rapid advances in our knowledge about the human genome. An on-line version derived and updated from these CDs is pending release through Twisted Ladder Media, and is entitled: "The New Genetics: Medicine and the Human Genome. Molecular Concepts, Applications, and Ramifications." In addition, Tobin and Boughton have collaborated on educational websites on inherited risk of breast cancer and on hereditary colorectal cancer with the Stanford Cancer Genetics Clinic.

    Tobin's current major research interests include an educational project funded by the National Science Foundation to create and evaluate innovative modules for undergraduates entitled, "The New Genetics: Electronic Tools for Educational Innovation." The modules are presented in on-line form as an electronic course and are accompanied by workbook exercises and problem sets. The content includes principles of genetics, molecular genetic technologies, applications in medicine, environmental biology, agriculture, and society, as well as implications. In addition, she is collaborating on two projects that are exploring the ramifications of using genetic information about addiction risk in the judicial system.

    Tobin is a member of the Benchside Consultation Team for the Center for the Integration of Research on Genetics and Ethics, and she evaluates clinical protocols for ethical issues for the Clinical Translational Research Program.

  • Michael Tracy

    Michael Tracy

    Clinical Assistant Professor, Pediatrics - Pulmonary Medicine

    BioDr. Tracy is a Clinical Assistant Professor in the Division of Pediatric Pulmonary. His clinical interests include care for children with bronchopulmonary dysplasia (BPD), chronic respiratory failure, mechanical ventilation, childhood interstitial lung disease, and cystic fibrosis. He serves as the director Pediatric Pulmonary BPD Program, and co-director of the Cardiac and Respiratory care for Infants with BPD (CRIB) Program. He is the medical director of the Stanford Technology Assisted Respiratory (STAR) Program and the physician lead for the inpatient Pulmonary consult service at LPCH. Dr. Tracy is currently involved in clinical research to improve care for infants with BPD. With regard to medical education, he was formerly a chief resident in pediatrics at LPCH, and has served as a faculty coach in the pediatric residency program.

  • Katherine Travis

    Katherine Travis

    Assistant Professor (Research) of Pediatrics (Developmental-Behavioral Pediatrics)

    BioDr. Katherine Travis is an Assistant Professor in the Division of Developmental-Behavioral Pediatrics at Stanford University. Dr. Travis obtained her Ph.D. in Neuroscience from the University of California San Diego. Dr. Travis came to Stanford as a postdoctoral fellow to obtain training in clinical neuroscience and translational approaches to intervention. As part of her training, she was awarded a K99/R00 Pathway to Independence grant from the National Institutes of Health.

    Her research uses human neuroimaging and behavioral measures to examine the neural bases of early language learning in infants and young children. The goal of her research is to develop therapies and interventions to help promote language learning outcomes in children at-risk for learning disabilities. Currently, she directs an NIH-funded clinical trial that will use diffusion MRI to assess whether there are changes in brain structure following a language intervention in the Neonatal Intensive Care Unit for preterm infants.